Bijblijven

, 22:155

Ouderdomsmaculadegeneratie

  • H. Vingerling
Artikel
  • 49 Downloads

Samenvatting

Ouderdomsmaculadegeneratie is een belangrijke oogziekte. Vroegtijdige onderkenning, snelle verwijzing bij suspecte symptomen en preventieve maatregelen bij de aanwezigheid van vroege kenmerken kunnen het aantal slechtzienden door ouderdomsmaculadegeneratie terugdringen. Behandeling is in de meeste gevallen nog niet goed mogelijk, maar nieuwe ontwikkelingen op dit gebied geven hoop op betere behandelmethodes in de nabije toekomst.

Literatuur

  1. Kuhnt PJP. Die scheibenförmige Entartung der Netzhautmitte. Berlin: Karger, 1926.Google Scholar
  2. Kini MM, Leibowitz HM, Colton T, Nickerson RJ, Ganley J, Dawber TR. Prevalence of senile cataract, diabetic retinopathy, senile macular degeneration, and open-angle glaucoma in the Framingham eye study. Am J Ophthalmol 1978;85:28-34.PubMedGoogle Scholar
  3. Leibowitz HM, Krueger DE, Maunder LR, Milton RC, Kini MM, Kahn HA, et al. The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Surv Ophthalmol 1980;24(Suppl):335-610.CrossRefPubMedGoogle Scholar
  4. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1992;99:933-43.Google Scholar
  5. Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia: The Blue Mountains Eye Study. Ophthalmology 1995;102:1450-60.PubMedGoogle Scholar
  6. Vingerling JR, Dielemans I, Hofman A, Grobbee DE, Hijmering M, Kramer CF, et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 1995;102:205-10.PubMedGoogle Scholar
  7. Leeuwen R van, Klaver CC, Vingerling JR, Hofman A, Jong PT de. Epidemiology of age-related maculopathy: A review. Eur J Epidemiol 2003;18:845-54.CrossRefPubMedGoogle Scholar
  8. Holz FG, Pauleikhoff D, Klein R, Bird AC. Pathogenesis of lesions in late age-related macular disease. Am J Ophthalmol 2004;137:504-10.CrossRefPubMedGoogle Scholar
  9. Blumenkranz MS, Russell SR, Robey MG, Kott-Blumenkranz R, Penneys N. Risk factors in age-related maculopathy complicated by choroidal neovascularization. Ophthalmology 1986;93:552-8.PubMedGoogle Scholar
  10. Hyman LG, Lilienfeld AM, Ferris 3rd FL, Fine SL. Senile macular degeneration: A case-control study. Am J Epidemiol 1983;118:213-27.Google Scholar
  11. Klein R, Klein BE, Linton KL, DeMets DL. The Beaver Dam Eye Study: The relation of age-related maculopathy to smoking. Am J Epidemiol 1993;137:190-200.PubMedGoogle Scholar
  12. Paetkau ME, Boyd TA, Grace M, Bach-Mills J, Winship B. Senile disciform macular degeneration and smoking. Can J Ophthalmol 1978;13:67-71.PubMedGoogle Scholar
  13. Seddon JM, Willett WC, Speizer FE, Hankinson SE. A prospective study of cigarette smoking and age-related macular degeneration in women.jama 1996;276:1141-6.CrossRefPubMedGoogle Scholar
  14. Vingerling JR, Hofman A, Grobbee DE, Jong PT de. Age-related macular degeneration and smoking: The Rotterdam Study. Arch Ophthalmol 1996;114:1193-6.PubMedGoogle Scholar
  15. Klein R, Peto T, Bird A, Vannewkirk MR. The epidemiology of age-related macular degeneration. Am J Ophthalmol 2004;137:486-95.CrossRefPubMedGoogle Scholar
  16. Thornton J, Edwards R, Mitchell P, Harrison RA, Buchan I, Kelly SP. Smoking and age-related macular degeneration: A review of association. Eye 2005;19:935-44.CrossRefPubMedGoogle Scholar
  17. Tomany SC, Wang JJ, Leeuwen R van, Klein R, Mitchell P, Vingerling JR, et al. Risk factors for incident age-related macular degeneration: Pooled findings from 3 continents. Ophthalmology 2004;111:1280-7.CrossRefPubMedGoogle Scholar
  18. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI, et al. A common haplotype in the complement regulatory gene factor H (hf1/cfh) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sciusa 2005;102:7227-32.CrossRefPubMedGoogle Scholar
  19. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005;308:385-9.CrossRefPubMedGoogle Scholar
  20. Seddon JM, Gensler G, Milton RC, Klein ML, Rifai N. Association between C-reactive protein and age-related macular degeneration.jama 2004;291:704-10.CrossRefPubMedGoogle Scholar
  21. Seddon JM, George S, Rosner B, Rifai N. Progression of age-related macular degeneration: Prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. Arch Ophthalmol 2005;123:774-82.CrossRefPubMedGoogle Scholar
  22. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss:areds report no. 8. Arch Ophthalmol 2001;119:1417-36.Google Scholar
  23. Leeuwen R van, Boekhoorn S, Vingerling JR, Witteman JC, Klaver CC, Hofman A, et al. Dietary intake of antioxidants and risk of age-related macular degeneration.jama 2005;294:3101-7.CrossRefPubMedGoogle Scholar
  24. Christen WG, Glynn RJ, Ajani UA, Schaumberg DA, Chew EY, Buring JE, et al. Age-related maculopathy in a randomized trial of low-dose aspirin amongus physicians. Arch Ophthalmol 2001;119:1143-9.PubMedGoogle Scholar
  25. Brown GC, Tasman WS, Shields JA. Massive subretinal hemorrhage and anticoagulant therapy. Can J Ophthalmol 1982;17:227-30.PubMedGoogle Scholar
  26. Tilanus MA, Vaandrager W, Cuypers MH, Verbeek AM, Hoyng CB. Relationship between anticoagulant medication and massive intraocular hemorrhage in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2000;238:482-5.CrossRefPubMedGoogle Scholar
  27. Bressler NM, Frost LA, Bressler SB, Murphy RP, Fine SL. Natural course of poorly defined choroidal neovascularization associated with macular degeneration. Arch Ophthalmol 1988;106:1537-42.PubMedGoogle Scholar
  28. Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study. Macular Photocoagulation Study Group. Arch Ophthalmol 1991;109:1242-57.Google Scholar
  29. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials–tap report: Treatment of age-related macular degeneration with photodynamic therapy (tap) Study Group. Arch Ophthalmol 1999;117:1329-45.Google Scholar
  30. Witmer AN, Vrensen GF, Noorden CJ van, Schlingemann RO. Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res 2003;22:1-29.CrossRefPubMedGoogle Scholar
  31. D’Amico DJ, Goldberg MF, Hudson H, Jerdan JA, Krueger DS, Luna SP, et al. Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: Twelve-month clinical outcomes. Ophthalmology 2003;110:2372-83; discussion 2384-5.CrossRefPubMedGoogle Scholar
  32. Gragoudas ES, Adamis AP, Cunningham ET Jr., Feinsod M, Guyer DR. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004;351:2805-16.CrossRefPubMedGoogle Scholar
  33. Rosenfeld PJ, Heier JS, Hantsbarger G, Shams N. Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degeneration. Ophthalmology 2006;113:632.e1.CrossRefGoogle Scholar
  34. Heier JS, Antoszyk AN, Pavan PR, Leff SR, Rosenfeld PJ, Ciulla TA, et al. Ranibizumab for treatment of neovascular age-related macular degeneration: A phase I/II multicenter, controlled, multidose study. Ophthalmology 2006;113:642.e1-4.Google Scholar
  35. Rosenfeld PJ, Moshfeghi AA, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 2005;36:331-5.PubMedGoogle Scholar
  36. Spaide RF, Laud K, Fine HF, Klancnik JM Jr., Meyerle CB, Yannuzzi LA, et al. Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina 2006;26:383-90.CrossRefPubMedGoogle Scholar
  37. Machemer R. Macular translocation. Am J Ophthalmol 1998;125:698-700.CrossRefPubMedGoogle Scholar
  38. Pertile G, Claes C. Macular translocation with 360 degree retinotomy for management of age-related macular degeneration with subfoveal choroidal neovascularization. Am J Ophthalmol 2002;134:560-5.CrossRefPubMedGoogle Scholar
  39. Meurs JC van, Biesen PR van den. Autologous retinal pigment epithelium and choroid translocation in patients with exudative age-related macular degeneration: Short-term follow-up. Am J Ophthalmol 2003;136:688-95.CrossRefPubMedGoogle Scholar

Copyright information

© Bohn Stafleu van Loghum 2006

Authors and Affiliations

  • H. Vingerling
    • 1
  1. 1.

Personalised recommendations